As described in a study published in Nature Signal Transduction and Targeted Therapy in late April, researchers looked into targeting the androgen receptors as a way to combat prostate cancer.
Kisunla (donanemab) is a new IV anti-amyloid beta-directed monoclonal antibody for adults with mild cognitive impairment or mild dementia due to Alzheimer's disease.
Based on a recent ISMP Canada safety bulletin, which of the following main themes have led to medication incidents associated with newer insulin products?
